对 "多发性骨髓瘤细胞外泌体miR-21-5p通过靶向TGF-β/SMAD7信号通路促进肾上皮-间充质转化 "的更正

IF 2.9 4区医学 Q2 Medicine

Clinical and Experimental Pharmacology and Physiology Pub Date : 2024-01-11 DOI:10.1111/1440-1681.13838

引用次数: 0

摘要

刘丽萍，刘兰妮，刘锐，刘静，程倩，《临床与实验药理学和生理学》，首次发表：2023年3月11日。https://doi.org/10.1111/1440-1681.13768In "基金资助 "和 "致谢 "部分，"湖南省自然科学基金 "编号有误。编号应为2021JJ40917，而不是2021JJ40916。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to “Exosomal miR-21-5p derived from multiple myeloma cells promote renal epithelial–mesenchymal transition through targeting TGF-β/SMAD7 signalling pathway”

Liping Liu, Langni Liu, Rui Liu, Jing Liu, Qian Cheng, Clinical and Experimental Pharmacology and Physiology, First published: 11 March 2023. https://doi.org/10.1111/1440-1681.13768

In paragraph of the “Funding” and “Acknowledgment” section, the number of “Hunan Provincial Natural Science Foundation of China” was incorrect. The number should be 2021JJ40917, not 2021JJ40916.

We apologize for this error.

Qian Cheng

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical and Experimental Pharmacology and Physiology 医学-生理学

CiteScore

6.20

自引率

0.00%

发文量

128

审稿时长

6 months

期刊介绍： Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.